Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Spero Therapeutics, Inc. | 75,000 | reported | 12 Jun 2025 | tx 8+108,219 |
| ACHILLION PHARMACEUTICALS INC | 40,000 | reported | 19 Dec 2006 | tx 1+40,000 |
| FS Development Corp. II | 0 | reported | 31 Aug 2023 | tx 4+112,500−112,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 12 Jun 2025 | GRANT_AWARD | Spero Therapeutics, Inc. | 20,000 | 0.00 USD | |
| 29 May 2024 | GRANT_AWARD | Spero Therapeutics, Inc. | 20,000 | 0.00 USD | |
| 05 Oct 2023 | GRANT_AWARD | Spero Therapeutics, Inc. | 20,000 | 0.00 USD | |
| 31 Aug 2023 | OTHER | FS Development Corp. II | 37,500 | — | deriv |
| 31 Aug 2023 | OTHER | FS Development Corp. II | 75,000 | — | deriv |
| 01 Jun 2023 | GRANT_AWARD | FS Development Corp. II | 37,500 | 0.00 USD | deriv |
| 15 Sept 2022 | GRANT_AWARD | Spero Therapeutics, Inc. | 15,000 | 0.00 USD | |
| 14 Sept 2022 | GRANT_AWARD | FS Development Corp. II | 75,000 | 0.00 USD | deriv |
| 17 Aug 2021 | GRANT_AWARD | Spero Therapeutics, Inc. | 7,500 | 0.00 USD | deriv |
| 27 Oct 2020 | GRANT_AWARD | Spero Therapeutics, Inc. | 7,500 | 0.00 USD | deriv |
| 05 Jun 2019 | GRANT_AWARD | Spero Therapeutics, Inc. | 6,073 | 0.00 USD | deriv |
| 21 Sept 2018 | GRANT_AWARD | Spero Therapeutics, Inc. | 12,146 | 0.00 USD | deriv |
| 19 Dec 2006 | GRANT_AWARD | ACHILLION PHARMACEUTICALS INC | 40,000 | 0.00 USD | deriv |